WPA Board Chair Andrew Spiegel Named Among "100 Most Influential CEOs in Oncology" for 2025 - World Patients Alliance

Wessington D.C, 12 January 2025.  The World Patients Alliance (WPA) is proud to announce that Andrew Spiegel, Esq. Chair Board of Directors, WPA has been recognized as one of the “100 Most Influential CEOs in Oncology in 2025" by OncoDaily. This prestigious list highlights leaders who have demonstrated exceptional stewardship, accountability, and impact in the global fight against cancer.

Andrew Spiegel’s recognition places him alongside some of the world's most prominent leaders in cancer care, including heads of major research institutions and pharmaceutical innovators. However, his inclusion is particularly significant for the WPA community because it underscores the critical importance of patient advocacy leadership at the highest levels of global health policy.

As the co-founder and Executive Director of the Global Colon Cancer Association (GCCA), Spiegel has spent nearly two decades uniting patient organizations to battle colorectal cancer, the third leading cause of cancer deaths worldwide. His work has been instrumental in reducing disparities in screening, diagnosis, and treatment, ensuring that patients everywhere have access to quality care.

Since taking on the role of Chair of the Board of Directors at the World Patients Alliance, Spiegel has brought that same tireless dedication to a broader spectrum of health issues. Under his guidance, the WPA has continued to expand its influence, ensuring that safe, affordable, and accessible healthcare is treated as a fundamental human right across the globe.

“This recognition is not just a personal honor, but a testament to the power of the patient voice," said Spiegel. “Whether we are discussing biosimilars, clinical trial participation, or equitable access to oncology treatments, our goal at WPA remains the same: to ensure patients are at the center of every healthcare decision."

Spiegel’s influence extends deep into health policy. His background as an attorney and his roles with the Alliance for Safe Biologic Medicines (ASBM) and the Digestive Disease National Coalition (DDNC) have positioned him as a key figure in navigating the complex regulatory landscapes that affect patient safety and treatment access.

The OncoDaily selection committee noted that the list recognizes leaders whose choices “shape the fight against cancer." For the WPA, Andrew Spiegel’s leadership ensures that this fight is always waged with the patient's perspective as the primary compass.

The World Patients Alliance (WPA) is the world's largest umbrella organization of patient organizations, representing patients from all world regions and across all disease areas. We work to ensure that patients have an active role in healthcare decision-making and access to safe, high-quality, and affordable care.